Dr. Broyles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1124 Columbia St
Ste 400
Seattle, WA 98104Phone+1 206-215-2440Fax+1 206-215-2457- Is this information wrong?
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1990 - 1992
Texas Health Resources (Dallas)Residency, Internal Medicine, 1987 - 1990
Albany Medical CenterInternship, Internal Medicine, 1984 - 1985
University of Florida College of MedicineClass of 1984
Certifications & Licensure
WA State Medical License 1990 - 2025
TX State Medical License 1986 - 1991- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Top MD Consumers Checkbook
Clinical Trials
- Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Start of enrollment: 2013 Jun 10
- An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Start of enrollment: 2014 May 23
Publications & Presentations
PubMed
- 2 citationsDiagnosis of Cushing's disease in a patient with consistently normal urinary free cortisol levels: a case report.Kelley J. Moloney, Jennifer U. Mercado, William H. Ludlam, Frances E. Broyles> ;Clinical Case Reports. 2016 Nov 9
- 44 citationsComparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.Robert H. Knopp, Frances E. Broyles, Marian Cheung, Katherine H. Moore, Santica M. Marcovina, Wayne L. Chandler> ;Contraception. 2001 Jan 1
- 7 citationsEffect of Pravastatin in the Treatment of Patients with Type III Hyperlipoproteinemia.Robert H. Knopp, D. Roger Illingworth, Evan A. Stein, Henry N. Ginsberg, Frances E. Broyles, Bruce D. Behounek> ;American Journal of Therapeutics. 1996 Nov 1
- Join now to see all
Press Mentions
High-Frequency Spinal Cord Stimulator Gets FDA NodJuly 19th, 2021
Hospital Affiliations
Swedish Cherry Hill CampusSeattle, Washington
Swedish IssaquahIssaquah, Washington
Swedish First Hill CampusSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
